Generation Bio (GBIO) Short Interest Ratio & Short Volume $0.44 +0.01 (+1.59%) Closing price 05/1/2025 04:00 PM EasternExtended Trading$0.45 +0.01 (+2.27%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Generation Bio Short Interest DataGeneration Bio (GBIO) has a short interest of 1.67 million shares, representing 3.65% of the float (the number of shares available for trading by the public). This marks a -1.18% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.5, indicating that it would take 3.5 days of the average trading volume of 283,557 shares to cover all short positions.Current Short Interest1,670,000 sharesPrevious Short Interest1,690,000 sharesChange Vs. Previous Month-1.18%Dollar Volume Sold Short$614,226.00Short Interest Ratio3.5 Days to CoverLast Record DateApril 15, 2025Outstanding Shares67,013,000 sharesFloat Size45,790,000 sharesShort Percent of Float3.65%Today's Trading Volume290,750 sharesAverage Trading Volume283,557 sharesToday's Volume Vs. Average103% Short Selling Generation Bio? Sign up to receive the latest short interest report for Generation Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartGBIO Short Interest Over TimeGBIO Days to Cover Over TimeGBIO Percentage of Float Shorted Over Time Generation Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,670,000 shares $614,226.00 -1.2%3.7%3.5 $0.37 3/31/20251,690,000 shares $684,450.00 +0.6%3.7%3.2 $0.41 3/15/20251,680,000 shares $806,400.00 -34.4%3.7%3.1 $0.48 2/28/20252,560,000 shares $1.48 million +2.4%5.6%5 $0.58 2/15/20252,500,000 shares $1.70 million +8.7%5.5%5.2 $0.68 1/31/20252,300,000 shares $1.79 million +6.5%5.0%5.1 $0.78 1/15/20252,160,000 shares $1.92 million +22.7%5.1%5.6 $0.89 12/31/20241,760,000 shares $1.87 million -1.1%4.1%6.1 $1.06 12/15/20241,780,000 shares $2.06 million +16.3%4.2%8 $1.16 11/30/20241,530,000 shares $2.33 million +3.4%3.3%10.3 $1.52 Get the Latest News and Ratings for GBIO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Generation Bio and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,480,000 shares $2.28 million -10.8%3.2%11.4 $1.54 10/31/20241,660,000 shares $3.62 million -4.6%3.4%15.2 $2.18 10/15/20241,740,000 shares $4.21 million -13.4%3.6%17.1 $2.42 9/30/20242,010,000 shares $4.96 million -6.1%4.1%19.2 $2.47 9/15/20242,140,000 shares $5.56 million +13.8%4.4%18.3 $2.60 8/31/20241,880,000 shares $4.96 million No Change3.9%15.5 $2.64 8/15/20241,880,000 shares $4.96 million +2.7%3.9%15.5 $2.64 7/31/20241,830,000 shares $6.11 million -4.2%3.8%13.3 $3.34 7/15/20241,910,000 shares $5.60 million +13.7%3.9%12 $2.93 6/30/20241,680,000 shares $4.74 million +10.5%3.5%9.7 $2.82 6/15/20241,520,000 shares $4.16 million -1.3%3.1%8.1 $2.74 5/31/20241,540,000 shares $4.90 million -4.9%3.2%7.5 $3.18 5/15/20241,620,000 shares $6.14 million -7.4%3.3%6.9 $3.79 4/30/20241,750,000 shares $4.95 million +10.8%3.6%7.2 $2.83 4/15/20241,580,000 shares $5.85 million +38.6%3.3%6.5 $3.70 3/31/20241,140,000 shares $4.64 million -10.2%2.4%4.2 $4.07 3/15/20241,270,000 shares $3.92 million -11.8%2.6%3.9 $3.09 2/29/20241,440,000 shares $3.61 million +0.7%3.0%3.5 $2.51 2/15/20241,430,000 shares $2.96 million -1.4%3.0%3 $2.07 1/31/20241,450,000 shares $2.73 million +16.0%3.0%2.5 $1.88 1/15/20241,250,000 shares $2.39 million +23.8%2.6%1.5 $1.91 12/31/20231,010,000 shares $1.67 million -25.2%2.1%1.2 $1.65 12/15/20231,350,000 shares $2.70 million -33.2%2.8%1.7 $2.00 11/30/20232,020,000 shares $2.28 million -34.6%4.2%2.9 $1.13 11/15/20233,090,000 shares $3.65 million +76.6%6.3%5.4 $1.18 10/31/20231,750,000 shares $1.64 million -3.3%3.6%3.8 $0.94 10/15/20231,810,000 shares $5.86 million +0.6%3.7%6.4 $3.24 9/30/20231,800,000 shares $6.82 million -12.2%3.7%14.7 $3.79 9/15/20232,050,000 shares $8.41 million +3.0%4.2%15.6 $4.10 8/31/20231,990,000 shares $9.51 million +2.6%4.1%13.2 $4.78Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 8/15/20231,940,000 shares $8.77 million -2.0%4.0%12 $4.52 7/31/20231,980,000 shares $10.06 million -2.9%4.1%11.7 $5.08 7/15/20232,040,000 shares $10.36 million +2.5%4.2%11.7 $5.08 6/30/20231,990,000 shares $10.95 million -8.3%4.1%10.9 $5.50 6/15/20232,170,000 shares $10.76 million -3.6%4.5%9.2 $4.96 5/31/20232,250,000 shares $7.88 million +6.6%4.8%5.1 $3.50 5/15/20232,110,000 shares $9.90 million -1.9%4.5%4.6 $4.69 4/30/20232,150,000 shares $10.58 million +4.9%4.6%4.6 $4.92 4/15/20232,050,000 shares $9.23 million -8.1%4.8%4.2 $4.50 3/31/20232,230,000 shares $9.59 million +55.9%5.1%4.6 $4.30 3/15/20231,430,000 shares $5.16 million +10.0%3.0%3.1 $3.61 2/28/20231,300,000 shares $5.15 million +0.8%2.7%5.8 $3.96 2/15/20231,290,000 shares $7.19 million -9.2%2.7%6.2 $5.57 1/31/20231,420,000 shares $8.38 million -3.4%3.0%7 $5.90 1/15/20231,470,000 shares $7.50 million -12.0%3.1%8 $5.10 12/30/20221,670,000 shares $6.56 million -19.3%3.5%9.1 $3.93 12/15/20222,070,000 shares $9.40 million -1.9%4.3%12.1 $4.54 11/30/20222,110,000 shares $11.25 million -14.2%4.4%11.8 $5.33 11/15/20222,460,000 shares $15.55 million -0.8%5.1%13.4 $6.32 10/31/20222,480,000 shares $12.70 million -6.4%5.2%11.2 $5.12 10/15/20222,650,000 shares $14.87 million -0.4%5.6%9.8 $5.61 9/30/20222,660,000 shares $14.12 million +5.1%5.6%8.9 $5.31 9/15/20222,530,000 shares $13.79 million -1.6%5.3%7.6 $5.45 8/31/20222,570,000 shares $13.16 million +0.8%5.4%6.8 $5.12 8/15/20222,550,000 shares $20.20 million -5.6%5.4%6.8 $7.92 7/31/20222,700,000 shares $17.23 million -2.5%5.9%7.3 $6.38 7/15/20222,770,000 shares $19.89 million -1.1%6.1%7.6 $7.18 6/30/20222,800,000 shares $18.37 million -11.7%6.1%7.5 $6.56 6/15/20223,170,000 shares $18.51 million -3.9%7.0%7.9 $5.84 5/31/20223,300,000 shares $18.55 million -1.8%7.2%8.1 $5.62 5/15/20223,360,000 shares $20.16 million -24.3%7.4%7.8 $6.00 4/30/20224,440,000 shares $28.11 million +6.0%9.5%9.8 $6.33 4/15/20224,190,000 shares $39.43 million +4.2%9.0%9.3 $9.41 3/31/20224,020,000 shares $29.51 million -13.7%8.6%8.1 $7.34 3/15/20224,660,000 shares $21.20 million +4.7%10.0%9.2 $4.55 2/28/20224,450,000 shares $22.78 million -0.5%9.5%7.5 $5.12 2/15/20224,470,000 shares $22.08 million +2.5%9.6%7.6 $4.94 1/31/20224,360,000 shares $28.34 million +9.0%9.6%8.2 $6.50 1/15/20224,000,000 shares $27.88 million +7.0%8.8%8.1 $6.97 12/31/20213,740,000 shares $26.48 million -33.7%8.2%8.4 $7.08 12/15/20215,640,000 shares $36.66 million -3.6%12.4%14.5 $6.50 11/30/20215,850,000 shares $100.44 million -1.5%12.9%23.9 $17.17 11/15/20215,940,000 shares $121.77 million -1.0%13.1%24.4 $20.50 10/29/20216,000,000 shares $125.76 million -1.2%13.2%22.7 $20.96 10/15/20216,070,000 shares $132.39 million +1.3%13.4%21.6 $21.81 9/30/20215,990,000 shares $150.17 million -6.3%13.2%20.3 $25.07 9/15/20216,390,000 shares $169.97 million -6.2%14.1%20.7 $26.60 8/31/20216,810,000 shares $170.25 million +1.6%15.2%22.2 $25.00 8/13/20216,700,000 shares $151.22 million +1.8%14.9%20.1 $22.57 7/30/20216,580,000 shares $143.05 million +7.5%14.7%19.7 $21.74Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the May 1st funding window clos 7/15/20216,120,000 shares $122.40 million +5.3%13.7%18.1 $20.00 6/30/20215,810,000 shares $156.29 million +5.1%13.0%15.9 $26.90 6/15/20215,530,000 shares $147.93 million +25.7%12.8%13.6 $26.75 5/28/20214,400,000 shares $150.74 million -5.6%10.2%9.4 $34.26 5/14/20214,660,000 shares $144.23 million +2.6%10.8%10.1 $30.95 4/30/20214,540,000 shares $170.98 million +2.7%11.4%9.6 $37.66 4/15/20214,420,000 shares $117.48 million +5.0%11.2%8.7 $26.58 3/31/20214,210,000 shares $111.94 million +159.9%10.7%6.2 $26.59 3/15/20211,620,000 shares $56.30 million +2.5%4.2%2.4 $34.75 2/26/20211,580,000 shares $54.48 million No Change4.3%2.7 $34.48 2/12/20211,580,000 shares $55.63 million -3.1%4.3%2.9 $35.21 1/29/20211,630,000 shares $42.38 million -36.8%4.9%3.1 $26.00 1/15/20212,580,000 shares $89.99 million No Change7.7%5.4 $34.88 GBIO Short Interest - Frequently Asked Questions What is Generation Bio's current short interest? Short interest is the volume of Generation Bio shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,670,000 shares of GBIO short. 3.65% of Generation Bio's shares are currently sold short. Learn More on Generation Bio's current short interest. What is a good short interest ratio for Generation Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GBIO shares currently have a short interest ratio of 4.0. Learn More on Generation Bio's short interest ratio. Which institutional investors are shorting Generation Bio? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Generation Bio: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Generation Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.65% of Generation Bio's floating shares are currently sold short. Is Generation Bio's short interest increasing or decreasing? Generation Bio saw a drop in short interest in April. As of April 15th, there was short interest totaling 1,670,000 shares, a drop of 1.2% from the previous total of 1,690,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Generation Bio's float size? Generation Bio currently has issued a total of 67,013,000 shares. Some of Generation Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Generation Bio currently has a public float of 45,790,000 shares. How does Generation Bio's short interest compare to its competitors? 3.65% of Generation Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Generation Bio: Enanta Pharmaceuticals, Inc. (14.13%), Editas Medicine, Inc. (15.65%), Procaps Group S.A. (0.12%), Neumora Therapeutics, Inc. (20.67%), Lexeo Therapeutics, Inc. (11.76%), Instil Bio, Inc. (16.45%), Senti Biosciences, Inc. (0.88%), RAPT Therapeutics, Inc. (12.25%), C4 Therapeutics, Inc. (11.97%), Zentalis Pharmaceuticals, Inc. (7.67%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Generation Bio stock? Short selling GBIO is an investing strategy that aims to generate trading profit from Generation Bio as its price is falling. GBIO shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Generation Bio? A short squeeze for Generation Bio occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of GBIO, which in turn drives the price of the stock up even further. How often is Generation Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GBIO, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies ENTA Short Interest Data EDIT Short Interest Data PROC Short Interest Data NMRA Short Interest Data LXEO Short Interest Data TIL Short Interest Data SNTI Short Interest Data RAPT Short Interest Data CCCC Short Interest Data ZNTL Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GBIO) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Generation Bio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Generation Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GBIO Stock Free GBIO Stock Alerts